What to Look for in a Peptide COA: Research Lab Verification Guide
Research Notice: This article covers research topics relevant to research peptides including GHK-Cu, BPC-157, and others — available from Palmetto Peptides for laboratory use only.
DISCLAIMER: This article is for educational and scientific research reference purposes only. All compounds discussed are not approved by the FDA for use in humans or animals. All data discussed here reflects preclinical animal research or laboratory use. Palmetto Peptides sells these compounds exclusively for in vitro and preclinical laboratory research. Nothing in this article constitutes medical advice.
What to Look for in a Peptide COA: Research Lab Verification Guide
Last Updated: May 14, 2026 | Reading Time: Approximately 10 minutes | Author: Palmetto Peptides Research Team
Quick Answer
A complete, trustworthy peptide COA must include: the compound's full name and CAS number, a unique batch/lot number, HPLC purity percentage with the actual chromatogram and method details, mass spectrometry data comparing observed to theoretical molecular weight, the name and accreditation of the testing laboratory, synthesis or manufacture date, expiry or retest date, endotoxin (LAL) test results, and physical appearance description. Any document missing multiple of these elements should be treated as incomplete.
The COA as a Research Document
A Certificate of Analysis (COA) is the primary quality document for a research peptide purchase. It is the analytical record that bridges the gap between what a supplier claims about their product and what the product actually is. Without a COA, a researcher has no objective basis for evaluating the compound they are working with — they are relying entirely on unverified assertions from an interested party.
A well-constructed COA is not just a formality. It contains specific analytical data generated by specific instruments using specific methods on a specific batch of material. Every one of those specifics matters, because they are what allow the document to be evaluated, questioned, and compared against independent references.
This guide walks through every element that should appear in a complete, trustworthy peptide COA — what it is, why it matters, and what it looks like when it's missing or problematic.
Element 1: Compound Name and Amino Acid Sequence
The COA should state the full compound name — not just a trade name or abbreviation, but the systematic name or the internationally recognized research name that unambiguously identifies the compound. For peptides, this should include the amino acid sequence or at minimum a reference to the standard sequence from which the compound is derived.
For example, a COA for BPC-157 should identify the compound as Body Protection Compound 157 and ideally note its sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. A COA identifying the compound only as "BPC-157" without sequence information provides less verification than one that includes the full sequence.
For modified peptides — such as those with fatty acid acylation (semaglutide, tirzepatide) or C-terminal amidation (ipamorelin) — the modification should be stated explicitly.
Element 2: CAS Number
The Chemical Abstracts Service (CAS) number is a universal numerical identifier for chemical substances. Every distinct chemical compound has a unique CAS number. Verifying that the CAS number on a COA matches the known CAS number for the stated compound is a basic identity check.
CAS numbers for common research peptides are publicly available through databases including ChemSpider, PubChem, and the CAS SciFinder registry. A CAS number mismatch — where the number on the COA does not correspond to the stated compound — is a serious documentation error.
Some modified peptides (particularly newer research compounds like retatrutide) may have CAS numbers assigned only recently or may appear under multiple CAS numbers depending on salt form. Researchers should verify the specific CAS against the specific compound form being purchased.
Element 3: Batch / Lot Number
The batch or lot number is arguably the single most important administrative element of a COA. It is what makes the document specific to the material being sold rather than a generic template.
Every legitimate synthesis operation assigns unique lot numbers to each batch of material. This number appears on the vial label, on the COA, and in the supplier's internal production records. It allows the COA to be traced back to a specific synthesis run with specific reagents, conditions, and analytical results.
When evaluating a supplier, check whether the lot number on the COA matches the lot number on the vial you received. If a supplier cannot confirm that the COA provided corresponds to the specific lot in your shipment, the COA provides no batch-specific assurance.
Element 4: HPLC Purity with Chromatogram and Method
The HPLC purity section is the analytical heart of a peptide COA. It should contain:
- Purity percentage: The calculated purity value (e.g., 98.7% by area) — but this is only meaningful when accompanied by the underlying data
- The chromatogram: The actual graphical output of the HPLC run, showing peaks at their elution times with labeled areas or relative percentages. This is the evidence; a purity number without the chromatogram is an assertion.
- Chromatographic method: Column type (e.g., C18, 4.6 × 150 mm, 5 μm particles), mobile phase composition (e.g., water with 0.1% TFA / acetonitrile with 0.1% TFA), gradient program, flow rate (e.g., 1.0 mL/min), UV detection wavelength (typically 210 or 220 nm), run time, and column temperature
- Integration method: How the peak areas were calculated and whether a correction factor was applied
Without the chromatographic method details, the purity value cannot be independently assessed for analytical rigor. Different methods applied to the same compound can yield slightly different purity values — knowing the method is essential for comparing COAs across batches or suppliers.
Element 5: Mass Spectrometry Data
Mass spectrometry (MS) data in a peptide COA confirms molecular identity. The key elements to look for are:
- Theoretical molecular weight: The calculated MW for the target compound based on its amino acid sequence and modifications
- Observed molecular weight (or m/z ratio): The actual value measured by the instrument
- Ionization method: ESI (Electrospray Ionization) or MALDI (Matrix-Assisted Laser Desorption/Ionization) — both are acceptable for peptide identity confirmation
- Charge state(s) observed: ESI-MS typically produces multiply charged ions for larger peptides; the COA should either show the observed m/z values or the calculated neutral mass from them
The observed molecular weight should match the theoretical value within ±0.5 Da (for monoisotopic masses of peptides under 3,000 Da) or within 0.01% (for larger peptides where average masses are used). Discrepancies outside these tolerances suggest a composition error.
A COA listing the theoretical MW without any observed MS data has not provided evidence of identity — it has provided a number that appears on the product label anyway. The value of MS data is in the comparison of observed to theoretical, not in stating the theoretical value alone.
Element 6: Testing Laboratory Name and Accreditation
As discussed in our article on how to verify research peptide purity, third-party testing provides independent verification that in-house testing cannot. The COA should identify the testing laboratory by name and, ideally, reference its accreditation status (e.g., ISO 17025, CAP accreditation, or equivalent).
A named laboratory can be independently verified. Researchers can check whether the lab exists, whether it performs the types of analysis described, and whether its accreditation is current. This is not possible with anonymous testing claims.
Element 7: Synthesis Date / Manufacture Date
The synthesis or manufacture date documents when the compound was produced. This information is necessary to assess the age of the compound relative to known stability data. A compound synthesized five years ago that has been stored under unknown conditions may be considerably less potent than fresh material — particularly for peptides sensitive to hydrolysis or oxidation.
The synthesis date also provides a reference point for the expiry or retest date. Without a synthesis date, expiry dating is unanchored.
Element 8: Expiry / Retest Date
The expiry or retest date specifies the end of the compound's guaranteed specification period under specified storage conditions. For research peptides, this is typically two to three years from synthesis for lyophilized material stored at -20°C, and significantly shorter for reconstituted solutions.
A COA claiming a compound is "indefinitely stable" or failing to provide any dating is providing false confidence. All compounds degrade over time; the question is the rate and the storage conditions required to minimize it. Proper expiry dating reflects documented stability testing or conservative estimates based on known compound class stability.
Element 9: Endotoxin (LAL) Test Results
Endotoxin contamination is a significant concern for research peptides used in any biological system. The Limulus Amebocyte Lysate (LAL) test quantifies endotoxin content. A complete COA should include endotoxin test results expressed in EU/mg or EU/mL, with the test method stated.
The absence of endotoxin data is a meaningful gap in the COA for any compound intended for biological research. Researchers working with cell cultures or in vivo animal models should specifically require endotoxin documentation. See our discussion in the context of analytical testing methods for research peptides for additional context on endotoxin relevance.
Element 10: Physical Appearance Description
A complete COA includes a physical appearance statement — for example, "White to off-white lyophilized powder" — with a pass/fail designation. This provides a simple but useful reference: if the material received looks dramatically different from the appearance description on the COA, this is a signal worth investigating.
COA Completeness Checklist
| COA Element | Complete COA Has | Incomplete / Suspicious If |
|---|---|---|
| Compound Name | Full systematic or research name; sequence for peptides | Trade name only; no sequence for multi-residue peptides |
| CAS Number | Matching, verifiable CAS for the specific compound | No CAS; incorrect CAS for the stated compound |
| Lot/Batch Number | Unique batch-specific identifier matching vial label | Absent; same lot number used for all products |
| HPLC Purity | % purity + full chromatogram + method details | % only, no chromatogram; no method stated |
| Mass Spectrometry | Observed MW vs. theoretical MW with ionization method | Theoretical MW only; observed vs. theoretical absent |
| Testing Laboratory | Named third-party lab with verifiable identity | Anonymous; internal testing only; lab cannot be verified |
| Synthesis Date | Specific date or date range of manufacture | Absent; vague "recently synthesized" language |
| Expiry / Retest Date | Specific date under defined storage conditions | Absent; "indefinitely stable" claims |
| Endotoxin (LAL) | EU/mg or EU/mL value with test method | Not mentioned; not tested |
| Appearance | Physical description with pass/fail | Absent |
| Storage Conditions | Recommended storage conditions for the compound | No storage guidance provided |
Applying COA Evaluation in Practice
When evaluating a supplier's COA documentation, the approach recommended for research labs is:
- Request the COA before purchase, not after. A reputable supplier makes this straightforward.
- Go through the checklist above systematically. Note which elements are present and which are absent.
- If the HPLC chromatogram is present, look at it. Is the baseline clean? Is there a dominant peak that clearly accounts for the vast majority of area? Are there identifiable minor peaks that represent the impurity load?
- If mass spec data is present, compare the observed MW to the theoretical MW from an independent source (such as a peptide MW calculator using the stated sequence). Do the numbers match?
- Verify the testing laboratory by name. Does it have an online presence? Is it an independent third-party lab?
- Check the synthesis date and expiry date. Is the compound within its specification period?
For broader context on what distinguishes trustworthy suppliers, see our articles on how to choose a trusted research peptide supplier, red flags from unreliable suppliers, and the existing overview understanding COAs for research peptides using GHK-Cu as a worked example.
Frequently Asked Questions
Is a COA the same as a spec sheet?
No. A specification sheet describes what a product is intended to be — its target parameters. A COA documents what a specific batch actually is — the measured results. A COA may include both the specification (what was targeted) and the actual result (what was measured), with a pass/fail designation indicating whether the batch met the specification. A spec sheet without actual test data is not a COA.
How can I tell if a COA has been fabricated?
Fabricated COAs can be difficult to detect visually if the fabricator has invested in making them look professional. The most reliable checks are: verify the testing laboratory independently (does it exist, does it perform this type of testing?), compare the chromatogram to what you would expect for the compound (does the peak elution pattern match known chromatographic behavior?), check for internal consistency (do all the numbers on the COA make sense together?), and when possible, obtain independent testing. Inconsistencies — retention times that don't make sense for the stated mobile phase gradient, molecular weights that don't match the stated sequence — are clues worth investigating.
Do I need mass spec data for every peptide I purchase?
For rigorous research, yes. HPLC purity alone cannot confirm molecular identity. The practical reality is that many research labs accept HPLC + mass spec as the minimum standard for research-grade compounds, and working with suppliers who routinely include both in their COA documentation is the straightforward way to meet this standard.
What is the difference between a batch COA and a product COA?
A product COA documents a typical or target specification for a product category — it might describe what a compound is like in general but not document any specific batch. A batch COA documents actual testing results from a specific lot of material. Only batch COAs are meaningful for quality verification purposes. Suppliers who provide only product-level documentation rather than batch-specific COAs should be asked to provide batch documentation.
How often should a supplier re-test their compounds?
COA data should reflect testing on the specific batch being sold. For large batches sold over extended periods, periodic stability retesting (consistent with the retest date on the COA) is appropriate. A COA with a synthesis date many years in the past and no retest data may not accurately represent the current state of the compound. Ask suppliers whether their inventory is periodically retested and what the retest interval is for long-stored compounds.
Peer-Reviewed Citations
- Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. "Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars." Nature Reviews Drug Discovery. 2012;11(7):527-540.
- United States Pharmacopeia. "<85> Bacterial Endotoxins Test." USP–NF. Current edition.
- International Organization for Standardization. "ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories." ISO; 2017.
- Mant CT, Hodges RS. "Analysis of peptides by high-performance liquid chromatography." Methods in Enzymology. 1991;193:185-227.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. "Stability of protein pharmaceuticals: an update." Pharmaceutical Research. 2010;27(4):544-575.
Final Disclaimer: All compounds discussed are research chemicals not approved by the FDA for human or veterinary use. All content here is for scientific and educational reference only. Palmetto Peptides sells these products exclusively for in vitro and preclinical laboratory research.
Authored by the Palmetto Peptides Research Team | Last Updated: May 14, 2026